Case report sustained tachyarrhythmias in cardiac hemochromatosis treated with sotalol

Italian Journal of Pediatrics

Volumn 27, Issue 6, 2001, Pages 912-915

  Massin, M M ^a   Coremans, C ^a   Dresse, M F ^a   Hoyoux, C ^a   Lepage, Philippe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Arrhythmia; Congestive heart failure; Sotalol; Treatment

Indexed keywords

EID: 0242617233     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kaufman KS, Papaefthymiou GC, Frankel RB, Rosenthal A. Nature of iron deposits on the cardiac walls in β-thalassemia by Mossbauer spectroscopy. Biochim Biophys Acta 1980;629:522-9.
2. Kyriacou K, Michaelides Y, Senkus R, Simamonian K, Pavlides N, Antoniades L, et al. Ultrastructural pathology of the heart in patients with β-thalassemia major. Ultrastruct Pathol 2000;24:75-81.
3. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications or iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
4. Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic severe, refractory anemia with hemochromatosis. Circulation 1964;30:698-705.
5. Engle MA. Cardiac involvement in Cooky's anemia. Ann NY Acad Sci 1969;119:694-702.
6. Fosburg MT, Nathan DG. Treatment of Cooley's anemia. Blood 1990;76:435-44.
7. Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Myocarditis in β-thalassemia major: a cause of heart failure. Circulation 1995;91:66-71.
8. Strobel JS, Fuisz AR, Epstein AE, Plumb VJ. Syncope and indncible ventricular fibrillation in a woman with hemochromatosis. J Interv Card Electrophysiol 1999;3:225-9.
9. Short EM, Winkle RA, Billingham ME. Myocardial involvement in idiopathic hemochromatosis: morphologic and clinical improvement following venosection. Am J Med 1978;71:378.
10. Mattheyses M, Hespel JP, Brissot P, Daubert JC, Hita de Nercy Y, Lancien G, et al. The cardiomyopathy of idiopathic hemochmmatosis. Arch Mal Coeur Vaiss 1978;71:371-9.
11. Kuryshev YA, Brittenham GM, Fujioka H, Kannan P, Shieh CC, Cohen SA, et al. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Circulation 1999;100:675-83.
12. Masini V, Santini M, Visca T. Miocardiopatia emocromatosica. Descrizione di un caso con registrazione del potenziali del fascio di His ed esame emodinamico. G Ital Cardiol 1976;6:140-5.
13. Yalcinkaya S, Kumbasar SD, Semiz E, Tosun Z, Paksoy N. Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodamne. J Electrocardiol 1997;30:147-9.
14. Massin M, von Bernuth G. Übersicht über die Venvendung von Antiarrhythmika für die Behandlung tachykarder Herzrhythmusstörungen im Kindesalter. Monatsschr Kinderheilkd 1996;144:11-25.
15. Hohnloser SH, Woosley RL. Drug therapy: Sotalol. N Engl J Med 1994;331:31-8.